[{"Assets_0_Q2_USD":117751992.0,"CommonStockSharesOutstanding_0_Q2_shares":46349514.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-31342153.0,"NetIncomeLoss_2_Q2_USD":-32569973.0,"NetIncomeLoss_1_Q2_USD":-14747831.0,"StockholdersEquity_0_Q2_USD":51759070.0,"Ticker":"ADMA","CIK":"1368514","name":"ADMA BIOLOGICS, INC.","OfficialName":"ADMA Biologics Inc Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"401636724.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180810"}]